MALCOLM S. ARTENSTEIN, M.D.; FRANCIS C. CADIGAN JR.; EDWARD L. BUESCHER
Since Dalldorf and Sickles (1) first described Coxsackie viruses in 1948, 30 distinct serotypes have been identified. Twenty-four are classed in group A and six in group B by characteristic pathology produced by infection of the suckling mouse (2, 3). Since then the group A viruses have been found to cause herpangina and central nervous system disease of varied clinical manifestations (3, 4). The group B viruses have generally been recognized to produce epidemics of aseptic meningitis and pleurodynia and to cause encephalomyocarditis in infants. The group B Coxsackie viruses have also been implicated in a number of other clinical
MALCOLM S. ARTENSTEIN, FRANCIS C. CADIGAN, EDWARD L. BUESCHER. Clinical and Epidemiological Features of Coxsackie Group B Virus Infections. Ann Intern Med. 1965;63:597–603. doi: 10.7326/0003-4819-63-4-597
Download citation file:
Published: Ann Intern Med. 1965;63(4):597-603.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use